[HTML][HTML] Tumor markers and their diagnostic significance in ovarian cancer

A Matsas, D Stefanoudakis, T Troupis, K Kontzoglou… - Life, 2023 - mdpi.com
Ovarian cancer (OC) is characterized by silent progression and late-stage diagnosis. It is
critical to detect and accurately diagnose the disease early to improve survival rates. Tumor …

Sensitivity and specificity of selected biomarkers and their combinations in the diagnosis of ovarian cancer

A Englisz, M Smycz-Kubańska, A Mielczarek-Palacz - Diagnostics, 2024 - mdpi.com
One of the greatest challenges in modern gynecological oncology is ovarian cancer. Despite
the numerous studies currently being conducted, it is still sometimes detected at late clinical …

High-grade serous ovarian cancer—A risk factor puzzle and screening fugitive

J Wilczyński, E Paradowska, M Wilczyński - Biomedicines, 2024 - mdpi.com
High-grade serous ovarian cancer (HGSOC) is the most lethal tumor of the female genital
tract. Despite extensive studies and the identification of some precursor lesions like serous …

Biomarkers in high grade serous ovarian cancer

M Bates, BM Mohamed, F Lewis, S O'Toole… - … et Biophysica Acta (BBA …, 2024 - Elsevier
High-grade serous ovarian cancer (HGSC) is the most common subtype of ovarian cancer.
HGSC patients typically present with advanced disease, which is often resistant to …

Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis

Z Zhang, Z Wei, L Zhao, C Gu… - Journal of Obstetrics and …, 2023 - Taylor & Francis
Ovarian cancer (OC) is characterised by heterogeneity that complicates the prediction of
patient survival and treatment outcomes. Here, we conducted analyses to predict the …

Ovarian cancer: Diagnosis and treatment strategies

X Li, Z Li, H Ma, X Li, H Zhai, X Li… - Oncology …, 2024 - spandidos-publications.com
Ovarian cancer is a malignant tumor that seriously endangers health. Early ovarian cancer
symptoms are frequently challenging to detect, resulting in a large proportion of patients …

Evaluation of the potential diagnostic utility of the determination of selected immunological and molecular parameters in patients with ovarian cancer

A Englisz, M Smycz-Kubańska, A Mielczarek-Palacz - Diagnostics, 2023 - mdpi.com
Ovarian cancer is one of the most serious challenges in modern gynaecological oncology.
Due to its non-specific symptoms and the lack of an effective screening procedure to detect …

Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer

S Dongyong, C Shulin, MA Yechen… - Journal of Central …, 2023 - pmc.ncbi.nlm.nih.gov
Objective Tumor markers have been widely used clinically. Detection of serum CA125 is one
of the commonly used clinical methods for early screening and early diagnosis of epithelial …

[HTML][HTML] Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis

AER Kartikasari, P Michel-Lara, H Exton, K Tekin-Sari… - Cancers, 2024 - mdpi.com
Background: Ovarian cancer (OC) remains the deadliest gynecological malignancy, despite
significant treatment advances. The absence of early detection tests results in advanced …

The glycogene alterations and potential effects in esophageal squamous cell carcinoma

X Feng, J Chen, J Lian, T Dong, Y Gao, X Zhang… - Cellular and Molecular …, 2024 - Springer
Background Aberrant glycosylation is one of the hallmarks of cancer. The profile of
glycoprotein expression caused by abnormal glycosylation has been revealed, while …